ClinicalTrials.gov
ClinicalTrials.gov Menu

Etirinotecan Pegol (NKTR-102) in NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01773109
Recruitment Status : Completed
First Posted : January 23, 2013
Last Update Posted : August 29, 2018
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2016
  Actual Study Completion Date : March 15, 2017